Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

HIV Infection

Free Subscription Articles published in HIV Med Retrieve available abstracts of 134 articles: HTML format Text format

Single Articles

March 2010
1. CALMY A , Bloch M, Wand H, Delhumeau C, et al
   No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial.
   HIV Med. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. DI VINCENZO P , Rusconi S, Adorni F, Vitiello P, et al
   Prevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA)dagger.
   HIV Med. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. MALLET VO , Sultanik PS, Vallet-Pichard A, Pol S, et al
   HIV-associated obliterative portopathy (HIV-OP) underlies cryptogenic liver disease in HIV-seropositive patients.
   HIV Med. 2010.
   PubMed     Text format     Related articles   
   
   
   
4. LATTUADA E , Vallone A, Lanzafame M, Corsini F, et al
   Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy.
   HIV Med. 2010.
   PubMed     Text format     Related articles   
   
   
   
5. KALICHMAN SC , Eaton L, Cherry C
   Sexually transmitted infections and infectiousness beliefs among people living with HIV/AIDS: implications for HIV treatment as prevention.
   HIV Med. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
6. REEKIE J , Mocroft A, Ledergerber B, Beniowski M, et al
   History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.
   HIV Med. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. MACIAS J , Gonzalez J, Ortega E, Tural C, et al
   Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice.
   HIV Med. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. KABAMBA-MUKADI B , Duquenne A, Henrivaux P, Musuamba F, et al
   HIV-1 proviral resistance mutations: usefulness in clinical practice.
   HIV Med. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. BEDIMO R , Westfall AO, Mugavero M, Drechsler H, et al
   Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients.
   HIV Med. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. ENGSIG F , Omland L, Larsen M, Rasmussen L, et al
    Risk of high-level viraemia in HIV-infected patients on successful antiretroviral treatment for more than 6 months.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. BANSI L , Sabin C, Delpech V, Hill T, et al
    Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. VON LINSTOW ML , Rosenfeldt V, Lebech AM, Storgaard M, et al
    Prevention of mother-to-child transmission of HIV in Denmark, 1994-2008.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. HAIDARA A , Chamberland A, Sylla M, Aboubacrine SA, et al
    High level of primary drug resistance in Mali.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. NKUIZE M , De Wit S, Muls V, Arvanitakis M, et al
    Upper gastrointestinal endoscopic findings in the era of highly active antiretroviral therapy.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. MUNDERI P , Walker AS, Kityo C, Babiker AG, et al
    Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. WAND H , Yan P, Wilson D, McDonald A, et al
    Increasing HIV transmission through male homosexual and heterosexual contact in Australia: results from an extended back-projection approach.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. SAMARANAYAKE A , Chen MY, McNeil J, Read TR, et al
    Definitions of antiretroviral treatment failure for measuring quality outcomes.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. LAZARUS JV , Nielsen KK
    HIV and people over 50 years old in Europe.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
19. FABBIANI M , Di Giambenedetto S, Ragazzoni E, Colafigli M, et al
    Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. PARCZEWSKI M , Leszczyszyn-Pynka M, Wnuk A, Urbanska A, et al
    Introduction of pharmacogenetic screening for the human leucocyte antigen (HLA) B*5701 variant in Polish HIV-infected patients.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. CADE WT , Reeds DN, Mondy KE, Overton ET, et al
    Yoga lifestyle intervention reduces blood pressure in HIV-infected adults with cardiovascular disease risk factors.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. BOER K , England K, Godfried MH, Thorne C, et al
    Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. RAMSETTY SK , Stuart LL, Blake RT, Parsons CH, et al
    Risks for methicillin-resistant Staphylococcus aureus colonization or infection among patients with HIV infection.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. SZCZECH LA , Menezes P, Byrd Quinlivan E, van der Horst C, et al
    Microalbuminuria predicts overt proteinuria among patients with HIV infection.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. BROOK G , Main J, Nelson M, Bhagani S, et al
    British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010.
    HIV Med. 2010;11:1-30.
    PubMed     Text format     Related articles   
    
    
    December 2009
26. GUILLEN S , Garcia San Miguel L, Resino S, Bellon JM, et al
    Opportunistic infections and organ-specific diseases in HIV-1-infected children: a cohort study (1990-2006).
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. LAURICHESSE JJ , Taieb A, Capoulade-Metay C, Katlama C, et al
    Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. BENNETT M , Strachan E, Uldall K
    Development and initial validation of a brief screener for focused HIV prevention efforts.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. MANOSUTHI W , Chetchotisakd P, Nolen T, Wallace D, et al
    Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. DETI E , Thiebaut R, Bonnet F, Lawson-Ayayi S, et al
    Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. POYNTEN I , Jin F, Prestage G, Kaldor J, et al
    Attitudes towards new HIV biomedical prevention technologies among a cohort of HIV-negative gay men in Sydney, Australia.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. GHEZZI S , Pacciarini F, Nozza S, Racca S, et al
    Persistence of CCR5 usage among primary human immunodeficiency virus isolates of individuals receiving intermittent interleukin-2.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. HANSEN BR , Haugaard SB, Jensen FK, Jensen JE, et al
    Long-term high-physiological-dose growth hormone reduces intra-abdominal fat in HIV-infected patients with a neutral effect on glucose metabolism.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. BERRY SA , Manabe YC, Moore RD, Gebo KA, et al
    Hospitalization risk following initiation of highly active antiretroviral therapy.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. MOORE DM , Zhang W, Yip B, Genebat M, et al
    Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. KIVELA PS , Krol A, Salminen MO, Ristola MA, et al
    Determinants of late HIV diagnosis among different transmission groups in Finland from 1985 to 2005.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. AWEEKA FT , Stek A, Best BM, Hu C, et al
    Lopinavir protein binding in HIV-1-infected pregnant women.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. JIN C , Zhao G, Zhang F, Feng L, et al
    The psychological status of HIV-positive people and their psychosocial experiences in eastern China.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. CAMBIANO V , Lampe FC, Rodger AJ, Smith CJ, et al
    Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. ARAGONES G , Beltran R, Rull A, Marsillach J, et al
    Pitfalls in measuring high-density lipoprotein cholesterol concentrations in HIV-infected patients.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
41. KRISTOFFERSEN US , Kofoed K, Kronborg G, Benfield T, et al
    Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV-1-infected individuals receiving combination antiretroviral therapy.
    HIV Med. 2009;10:627-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
42. KOWALSKA J , Kirk O, Mocroft A, Hoj L, et al
    Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. BELPERIO P , Mole L, Boothroyd D, Backus L, et al
    Trends in uptake of recently approved antiretrovirals within a national healthcare system.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. PARRA S , Coll B, Aragones G, Marsillach J, et al
    Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. CESARI M , Caramma I, Antinori S, Adorni F, et al
    Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV/HCV-coinfected patients.
    HIV Med. 2009;10:580-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. SUAREZ-LOZANO I , Viciana P, Lacalle JR, Teira R, et al
    The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naive HIV-1-infected patients.
    HIV Med. 2009;10:573-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. GUTIERREZ EB , Gomes V, Picone CM, Suga H, et al
    Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS.
    HIV Med. 2009;10:564-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. RAMOS J
    Boosted protease inhibitors as a therapeutic option in the treatment of HIV-infected children.
    HIV Med. 2009;10:536-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. HILL A , Sawyer W
    Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients.
    HIV Med. 2009;10:527-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
50. KUMARASAMY N , Venkatesh K, Srikrishnan A, Prasad L, et al
    Risk factors for HIV transmission among heterosexual discordant couples in South India.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. SKEIE L , Bugge H, Negaard A, Bergersen B, et al
    Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. ORKIN C , Sadiq S, Rice L, Jackson F, et al
    Prospective epidemiological study of the prevalence of human leukocyte antigen (HLA)-B5701 in HIV-1-infected UK subjects.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. MICHELOUD D , Gonzalez-Nicolas J, Berenguer J, Lorente R, et al
    CD81 expression in peripheral blood lymphocytes before and after treatment with interferon and ribavirin in HIV/HCV coinfected patients.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. JUSTICE AC , McGinnis KA, Skanderson M, Chang CC, et al
    Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. TRABUT JB , Mallet V, Pol S
    Aspartate aminotransferase to platelet ratio index (APRI) score is inappropriate for assessment of liver fibrosis in HIV-infected patients with hazardous drinking.
    HIV Med. 2009;10:524.
    PubMed     Text format     Related articles   
    
    
    
56. KALU E , Wood R, Vourliotis M, Gilling-Smith C, et al
    Fertility needs and funding in couples with blood-borne viral infection.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. GILSON R , Man SL, Copas A, Rider A, et al
    Discordant responses on starting highly active antiretroviral therapy: suboptimal CD4 increases despite early viral suppression in the UK Collaborative HIV Cohort (UK CHIC) Study.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. SCHERRER AU , Hasse B, von Wyl V, Yerly S, et al
    Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS).
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
59. HARTE D , Dosekun O, Sethi G, Chadborn T, et al
    Immunosuppression among HIV-1-positive patients attending for care: experience from two large HIV centres in the United Kingdom.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. JOSEPHS J , Fleishman J, Korthuis P, Moore R, et al
    Emergency department utilization among HIV-infected patients in a multisite multistate study.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. OBEL N , Farkas D, Kronborg G, Larsen C, et al
    Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. GHOSN J , Flandre P, Cohen-Codar I, Girard PM, et al
    Long-term (96-week) follow-up of antiretroviral-naive HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. GIUNTINI R , Martinelli C, Ricci E, Vichi F, et al
    Efficacy and safety of boosted and unboosted atazanavir-containing antiretroviral regimens in real life: results from a multicentre cohort study.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. RESINO S , Micheloud D, Miralles P, Bellon JM, et al
    Diagnosis of advanced fibrosis in HIV and hepatitis C virus-coinfected patients via a new noninvasive index: the HGM-3 index.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. MURILLO W , de Rivera IL, Parham L, Jovel E, et al
    Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
66. FUSTER M , Estrada V, Fernandez-Pinilla M, Fuentes-Ferrer M, et al
    Smoking cessation in HIV patients: rate of success and associated factors.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. DIABATE S , Alary M
    Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Cote d'Ivoire.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. LAURENT C , Bourgeois A, Mpoudi-Ngole E, Kouanfack C, et al
    High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. HUNG CC , Chang SY, Su CT, Chen YY, et al
    A 5-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. TAIWO B , Li X, Palella F, Jacobson L, et al
    Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. RODKJAER L , Laursen T, Balle N, Sodemann M, et al
    Depression in patients with HIV is under-diagnosed: a cross-sectional study in Denmark.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. HILL A , Marcelin AG, Calvez V
    Identification of new genotypic cut-off levels to predict the efficacy of lopinavir/ritonavir and darunavir/ritonavir in the TITAN trial.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. MOYANO S , Ordi J, Caballero M, Garcia F, et al
    Laryngeal squamous cell carcinoma in HIV-positive patients: lack of association with human papillomavirus infection.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. ZHOU J , Li P, Kumarasamy N, Boyd M, et al
    Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD).
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. GUTIERREZ F , Bernal E, Masia M
    Considerations on ankle-brachial index interpretation in HIV-1 infected patients.
    HIV Med. 2009;10:395.
    PubMed     Text format     Related articles   
    
    
    June 2009
76. LORELLO G , la Porte C, Pilon R, Zhang G, et al
    Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. FORRESTER JE , McGovern BH, Rhee MS, Sterling RK, et al
    The individual and combined influence of HIV and hepatitis C virus on dyslipidaemia in a high-risk Hispanic population.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. STERNFELD T , Tischleder A, Schuster M, Bogner JR, et al
    Mitochondrial membrane potential and apoptosis of blood mononuclear cells in untreated HIV-1 infected patients.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
79. POWERS V , Ward J, Gompels M
    CYP2B6 G516T genotyping in a UK cohort of HIV-positive patients: polymorphism frequency and influence on efavirenz discontinuation.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. DAILLY E , Raffi F, Perre P, Martin J, et al
    Influence of darunavir coadministration on nevirapine pharmacokinetics in HIV-infected patients: a population approach.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. CRANE HM , Grunfeld C, Harrington RD, Kitahata MM, et al
    Lipoatrophy and lipohypertrophy are independently associated with hypertension.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. PUGLIESE P , Cuzin L, Cabie A, Poizot-Martin I, et al
    A large French prospective cohort of HIV-infected patients: the Nadis Cohort.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. FOSTER C , Lyall H, Olmscheid B, Pearce G, et al
    Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. ONEN NF , Overton ET, Presti R, Blair C, et al
    Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. DINH MH , Stosor V, Rao SM, Miller FH, et al
    Cryptogenic liver disease in HIV-seropositive men.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. COLAFIGLI M , Di Giambenedetto S, Bracciale L, Fanti I, et al
    Long-term follow-up of nevirapine-treated patients in a single-centre cohort.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. COMBESCURE C , Vallier N, Ledergerber B, Cavassini M, et al
    How reliable is an undetectable viral load?
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. PALMISANO L , Giuliano M, Galluzzo CM, Amici R, et al
    The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapy.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. WOODWARD CL , Hall AM, Williams IG, Madge S, et al
    Tenofovir-associated renal and bone toxicity.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. GRAU I , Ardanuy C, Linares J, Podzamczer D, et al
    Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
91. FOX J , White PJ, Macdonald N, Weber J, et al
    Reductions in HIV transmission risk behaviour following diagnosis of primary HIV infection: a cohort of high-risk men who have sex with men.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. MARCHETTI G , Riva A, Cesari M, Bellistri GM, et al
    HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. 
    Abstracts of the 15th Annual Conference of the British HIV Association, 1-3 April 2009, Liverpool, UK.
    HIV Med. 2009;10 Suppl 1:1-56.
    PubMed     Text format     Related articles   
    
    
    March 2009
94. HANSEN BR , Petersen J, Haugaard SB, Madsbad S, et al
    The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. LEE CC , Sun YJ, Barkham T, Leo YS, et al
    Primary drug resistance and transmission analysis of HIV-1 in acute and recent drug-naive seroconverters in Singapore.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. WILSON SL , Scullard G, Fidler SJ, Weber JN, et al
    Effects of HIV status and antiretroviral therapy on blood pressure.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. ESPINOSA E , Pena-Jimenez A, Ormsby CE, Vega-Barrientos R, et al
    Later onset of herpes zoster-associated immune reconstitution inflammatory syndrome.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. WEBER R , Huber M, Rickenbach M, Furrer H, et al
    Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. BANI-SADR F , Barange K, Daoud F, Jacomet C, et al
    Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis.
    HIV Med. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. STREET E , Curtis H, Sabin CA, Monteiro EF, et al
     British HIV Association (BHIVA) national cohort outcomes audit of patients commencing antiretrovirals from naive.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. OVERTON ET , Nurutdinova D, Freeman J, Seyfried W, et al
     Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. BENN P , Sauret-Jackson V, Cartledge J, Ruff C, et al
     Improvements in cheek volume in lipoatrophic individuals switching away from thymidine nucleoside reverse transcriptase inhibitors.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. IMAZ A , Falco V, Penaranda M, Jordano Q, et al
     Impact of prior pneumococcal vaccination on clinical outcomes in HIV-infected adult patients hospitalized with invasive pneumococcal disease.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. KNOBEL H , Urbina O, Gonzalez A, Sorli ML, et al
     Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term follow-up.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. CAREY D , Baker D, Petoumenos K, Chuah J, et al
     Poly-l-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-up.
     HIV Med. 2009;10:163-172.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. PALACIOS R , Senise J, Vaz M, Diaz R, et al
     Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
     HIV Med. 2009;10:157-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. PIRKLE C , Boileau C, Nguyen VK, Machouf N, et al
     Impact of a modified directly administered antiretroviral treatment intervention on virological outcome in HIV-infected patients treated in Burkina Faso and Mali.
     HIV Med. 2009;10:152-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
108. ROSENTHAL E , Salmon-Ceron D, Lewden C, Bouteloup V, et al
     Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 Study in collaboration with the Mortalite 2005 survey, ANRS EN19).
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. CAMPBELL L , Ibrahim F, Fisher M, Holt S, et al
     Spectrum of chronic kidney disease in HIV-infected patients.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. LO YC , Chen MY, Sheng WH, Hsieh SM, et al
     Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. ALVAREZ-URIA G , Ratcliffe L, Vilar JF
     Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. DRUYTS EF , Rachlis BS, Lima VD, Harvard SS, et al
     Mortality is influenced by locality in a major HIV/AIDS epidemic.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. TOMAKA F , Lefebvre E, Sekar V, Van Baelen B, et al
     Effects of ritonavir-boosted darunavir vs. ritonavir-boosted atazanavir on lipid and glucose parameters in HIV-negative, healthy volunteers.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. YENI P , Lamarca A, Berger D, Cimoch P, et al
     Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naive patients: results of the EPIC study (CCR100136).
     HIV Med. 2009;10:116-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. BERGROTH T , Ekici H, Gisslen M, Hagberg L, et al
     Difference in drug resistance patterns between minor HIV-1 populations in cerebrospinal fluid and plasma.
     HIV Med. 2009;10:111-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. VALCOUR V , Yeh TM, Bartt R, Clifford D, et al
     Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection.
     HIV Med. 2009;10:103-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. BARQASHO B , Nowak P, Tjernlund A, Kinloch S, et al
     Kinetics of plasma cytokines and chemokines during primary HIV-1 infection and after analytical treatment interruption.
     HIV Med. 2009;10:94-102.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. DRUYTS EF , Yip B, Lima VD, Burke TA, et al
     Health care services utilization stratified by virological and immunological markers of HIV: evidence from a universal health care setting.
     HIV Med. 2009;10:88-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. KRISTOFFERSEN US , Kofoed K, Kronborg G, Giger AK, et al
     Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy.
     HIV Med. 2009;10:79-87.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
120. AUDSLEY J , Arrifin N, Yuen L, Ayres A, et al
     Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. LANOY E , Lewden C, Lievre L, Tattevin P, et al
     How does loss to follow-up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalite 2000 survey and death certificates.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. DOLLFUS C , Blanche S, Trocme N, Funck-Brentano I, et al
     Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. RAVASI G , Lauriola M, Tinelli C, Brandolini M, et al
     Comparison of glomerular filtration rate estimates vs. 24-h creatinine clearance in HIV-positive patients.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. JUDD A , Ferrand R, Jungmann E, Foster C, et al
     Vertically acquired HIV diagnosed in adolescence and early adulthood in the United Kingdom and Ireland: findings from national surveillance.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. SKINNER S , Adewale A, Deblock L, Gill M, et al
     Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. MARTINEZ E , Larrousse M, Podzamczer D, Gatell J, et al
     Objective amount of limb fat in HIV-infected subjects with subjective diagnosis of lipoatrophy.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. GUINOT D , Ho M, Poynten I, McAllister J, et al
     Cost-effectiveness of HIV nonoccupational post-exposure prophylaxis in Australia.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. BATZING-FEIGENBAUM J , Loschen S, Gohlke-Micknis S, Hintsche B, et al
     Implications of and perspectives on HIV surveillance using a serological method to measure recent HIV infections in newly diagnosed individuals: results from a pilot study in Berlin, Germany, in 2005-2007.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. PADUA E , Almeida C, Nunes B, Cortes Martins H, et al
     Assessment of mother-to-child HIV-1 and HIV-2 transmission: an AIDS reference laboratory collaborative study.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. LIN CY , Sun HY, Chen MY, Hsieh SM, et al
     Aetiology of cavitary lung lesions in patients with HIV infection.
     HIV Med. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
131. CHAUDHRY A , Sulkowski M, Chander G, Moore R, et al
     Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort.
     HIV Med. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. BYAKWAGA H , Zhou J, Petoumenos K, Law M, et al
     Effect of nucleoside reverse transcriptase inhibitors on CD4 T-cell recovery in HIV-1-infected individuals receiving long-term fully suppressive combination antiretroviral therapy.
     HIV Med. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
133. KATZENSTEIN TL , Gerstoft J
     Zidovudine monotherapy in pregnancy: is it state of the art?
     HIV Med. 2008;9:445-7.
     PubMed     Text format     Related articles   
     
     
     July 2008
134. MAITLAND D , Jackson A, Osorio J, Mandalia S, et al
     Switching from twice-daily abacavir and lamivudine to the once-daily fixed-dose combination tablet of abacavir and lamivudine improves patient adherence and satisfaction with therapy.
     HIV Med. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: